Literature DB >> 33709395

Letter: ustekinumab for the treatment of post-surgical and refractory Crohn's disease.

Antonio Tursi1,2, Giammarco Mocci3, Marcello Picchio4, Walter Elisei5, Giovanni Maconi6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33709395     DOI： 10.1111/apt.16281

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  1 in total

Review 1.  Ustekinumab in Crohn's Disease: New Data for Positioning in Treatment Algorithm.

Authors:  Ferdinando D'Amico; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  J Crohns Colitis       Date:  2022-05-11       Impact factor: 10.020
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.